Links:
• Home
• About Us
• Our Strategy
• Executive Team
• Products
• Business Dev
• Contact Us

January 8, 2010
Gentalyn Receives Marketing Authorization in Chile

September 23, 2009
BurnsAdler Partners with Three Rivers Pharmaceuticals to Commercialize Infergen in Brazil and Chile

September 10, 2008
BurnsAdler Announces Named Patient Access Program for Latin America in Collaboration with DOR BioPharma

March 24, 2008
Collatamp™ EG Receives Marketing Authorization in Brazil


March 5, 2007              BurnsAdler Partners with X-GEN to Return Colistimethate for Injection to the Mexican Market